Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin in sub-optimally treated type 2 diabetes
NCT00511732Phase 2Completed
- Sponsor
- MannKind
- Start
- Jun 2004
- Primary completion
- Aug 2005
- Modality
- Biologic
01
Overview
A Phase 2 trial of Technosphere insulin in type 2 diabetes mellitus (T2DM), sponsored by MannKind. Started Jun 2004; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00511732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511732.